| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PROS.10246 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.10246 |
| https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.10246 | ||
| P698 | PubMed publication ID | 12712408 |
| P2093 | author name string | Liang Cheng | |
| Shaobo Zhang | |||
| John N. Eble | |||
| Guangyuan Zeng | |||
| Ronald C. McGarry | |||
| David S. Wilkes | |||
| Gerry E. Reed | |||
| P2860 | cites work | Dendritic cells and the control of immunity | Q27860918 |
| The dendritic cell system and its role in immunogenicity | Q29619870 | ||
| Immunotherapy of cancer with dendritic-cell-based vaccines | Q32066652 | ||
| Dendritic cell vaccines for cancer immunotherapy | Q33540299 | ||
| Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma | Q36119828 | ||
| Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines | Q36366108 | ||
| Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors | Q36380683 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model | Q40937528 | ||
| Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas | Q45862841 | ||
| Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. | Q53516187 | ||
| Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration | Q57779785 | ||
| Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity | Q71563753 | ||
| IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo | Q71871168 | ||
| Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen | Q71931319 | ||
| Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts | Q73209043 | ||
| Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow | Q73592993 | ||
| Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides | Q74744883 | ||
| Migration of human dendritic cells after injection in patients with metastatic malignancies | Q77804763 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | urology | Q105650 |
| oncology | Q162555 | ||
| dendritic cell | Q506253 | ||
| P304 | page(s) | 292-298 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Dendritic cells transfected with interleukin-12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo | |
| Dendritic cells transfected with interleukin‐12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo | |||
| P478 | volume | 55 |
| Q34649397 | Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies. |
| Q41520681 | Dendritic cells in cancer immunotherapy: vaccines or autologous transplants? |
| Q37513871 | Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4 |
| Q36751608 | Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines |
| Q47105622 | Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review |
| Q46343870 | Inhibition of prostate cancer metastasis by administration of a tissue vaccine |
| Q37735454 | Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors |
| Q92441659 | Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill |
Search more.